Atorvastatin API Market Overview

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

The Global Atorvastatin API Market is estimated to be valued at USD 2,852.3 Million by 2030 and is expected to register a CAGR of 7.50% during the forecast period.

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2022 to 2030.

Atorvastatin API Market Segmentation

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023

Atorvastatin API Market Regional Analysis

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.

The European market is estimated to exceed USD 1,31,094.04 thousand by 2023. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the growth of the Atorvastatin API market in the region. France is the major contributor to the growth of the regional market, followed by the UK.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

Atorvastatin API Market Players

• Globus Medical, Inc. (U.S.)
• Depuy Synthes Inc. (Johnson & Johnson) (U.S.)
• Smith & Nephew plc. (UK)
• NuVasive, Inc. (U.S.)
• Stryker Corporation (U.S.)
• Integra LifeSciences Holdings Corporation (U.S.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Medtronic, plc (Ireland)
• Wright Medical Group N.V. (Netherlands)
• The Orthopedic Implant Company (U.S.)
• Aesculap Implant Systems (U.S.)
• Conmed Corporation (U.S.)
• BioTek Instruments, Inc. (U.S.)
• Arthrocare Corporation (U.S.)

among others are some key companies in the global Atorvastatin API that are listed by MRFR for market research.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com